These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26361781)

  • 1. The Proteolytic Systems of Muscle Wasting.
    Scicchitano BM; Faraldi M; Musarò A
    Recent Adv DNA Gene Seq; 2015; 9(1):26-35. PubMed ID: 26361781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of skeletal muscle atrophy.
    Ventadour S; Attaix D
    Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Muscle Regeneration in Cancer-Associated Cachexia.
    Arneson PC; Doles JD
    Trends Cancer; 2019 Oct; 5(10):579-582. PubMed ID: 31706505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca(2+)-dependent proteolysis in muscle wasting.
    Costelli P; Reffo P; Penna F; Autelli R; Bonelli G; Baccino FM
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2134-46. PubMed ID: 15893952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
    Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
    Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle wasting in cancer: the role of mitochondria.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Clin Nutr Metab Care; 2015 May; 18(3):221-5. PubMed ID: 25769061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?
    Fontes-Oliveira CC; Busquets S; Toledo M; Penna F; Paz Aylwin M; Sirisi S; Silva AP; Orpí M; García A; Sette A; Inês Genovese M; Olivan M; López-Soriano FJ; Argilés JM
    Biochim Biophys Acta; 2013 Mar; 1830(3):2770-8. PubMed ID: 23200745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle wasting: an overview of recent developments in basic research.
    Palus S; von Haehling S; Springer J
    Int J Cardiol; 2014 Oct; 176(3):640-4. PubMed ID: 25205489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
    Talbert EE; Guttridge DC
    Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathways controlling skeletal muscle mass.
    Egerman MA; Glass DJ
    Crit Rev Biochem Mol Biol; 2014; 49(1):59-68. PubMed ID: 24237131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling pathways perturbing muscle mass.
    Glass DJ
    Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):225-9. PubMed ID: 20397318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
    Koopman R; Ryall JG; Church JE; Lynch GS
    Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):601-6. PubMed ID: 19741516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle.
    Wang X; Blagden C; Fan J; Nowak SJ; Taniuchi I; Littman DR; Burden SJ
    Genes Dev; 2005 Jul; 19(14):1715-22. PubMed ID: 16024660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α and cancer cachexia: Molecular insights and clinical implications.
    Patel HJ; Patel BM
    Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle.
    Braun TP; Grossberg AJ; Krasnow SM; Levasseur PR; Szumowski M; Zhu XX; Maxson JE; Knoll JG; Barnes AP; Marks DL
    FASEB J; 2013 Sep; 27(9):3572-82. PubMed ID: 23733748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle Changes During Atrophy.
    Dumitru A; Radu BM; Radu M; Cretoiu SM
    Adv Exp Med Biol; 2018; 1088():73-92. PubMed ID: 30390248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of peripheral muscle wasting in cardiac cachexia.
    Filippatos GS; Anker SD; Kremastinos DT
    Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):249-54. PubMed ID: 15809526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP-ubiquitin-dependent proteolysis.
    Costelli P; Baccino FM
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):407-12. PubMed ID: 12806214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the ubiquitin-proteasome pathway in muscle atrophy in cachexia.
    Attaix D; Combaret L; Béchet D; Taillandier D
    Curr Opin Support Palliat Care; 2008 Dec; 2(4):262-6. PubMed ID: 19069311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.